M Li
Impact in
-
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
-
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
Papers in
-
- Ubiquitin and proteasome pathways 3
- Epigenetics and DNA Methylation 1
- Extracellular vesicles in disease 1
- Oncology 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Christopher Brooks (2 shared papers)Y. Kobayashi (2 shared papers)Wei Gu (2 shared papers)Ning Kon (2 shared papers)Thomas Ludwig (2 shared papers)Wei Gu (1 shared paper)Yigong Shi (1 shared paper)Min Hu (1 shared paper)
- Journals
- Oncogene (2 papers)Medicine (1 paper)Cell Death and Differentiation (1 paper)Cytotechnology (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
M Li
3 papers receiving 325 citations
Peers
Comparison fields: 5 of 35
- Oncology 164
- Molecular Biology 302
- Cancer Research 45
- Cell Biology 29
- Genetics 46
Countries citing papers authored by M Li
This map shows the geographic impact of M Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Li more than expected).
Fields of papers citing papers by M Li
This network shows the impact of papers produced by M Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Li. The network helps show where M Li may publish in the future.
Co-authors
The 14 scholars most cited alongside M Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 149 | |
| 2 | 2007 | 121 | |
| 3 | 2011 | 62 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 |
About M Li
M Li is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 5 papers that have together received 332 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Epigenetics and DNA Methylation (1 paper), Ferroptosis and cancer prognosis (1 paper), MicroRNA in disease regulation (1 paper) and Extracellular vesicles in disease (1 paper). The work is most often cited by research in Oncology (164 citations), Molecular Biology (302 citations), Cancer Research (45 citations), Cell Biology (29 citations) and Genetics (46 citations). M Li has collaborated with scholars based in United States and China. Frequent co-authors include Christopher Brooks, Y. Kobayashi, Wei Gu, Ning Kon, Thomas Ludwig, Wei Gu, Yigong Shi, Min Hu, M Szabolcs and Jun Zhong. Their work appears in journals such as Oncogene, Medicine, Cell Death and Differentiation and Cytotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.